News CD20 market heats up as FDA OKs AbbVie, Genmab bispecific AbbVie and partner Genmab have FDA approval for the lead drug in their $3.9 billion cancer
News Bayer hits "turning point" in recovery plan, says CEO Bayer's pharma unit has reached a "turning point" in its growth trajectory as sales of new medicines rose 6.4% in Q3, says CEO Bill Anderson.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
